National Institute of Pharmaceutical Education and Research

Recent papers from National Institute of Pharmaceutical Education and Research

1. Investigation of astaxanthin-loaded hollow gold nanoparticles in mitigating the EAE mice model of multiple sclerosisTherapeutic Delivery · 2026
2. Unravelling disease ionomics: An ionome perspective on cancer and metabolic healthAdvances in Biomarker Sciences and Technology · 2026
3. Combined Heavy Metal Exposure and Metabolic Health: Epidemiological Evidence, Mechanistic Pathways, and Mixture ToxicologyEnvironmental Toxicology · 2026
4. Civora Nexus: A Case Study of a Student-Founded Civic and Education Technology Company in Nashik, India2026
5. Nitric Oxide Signaling in Cardiovascular Disease: Redox Dysregulation, Biomarkers, and Therapeutic ChallengesAntioxidants · 2026
6. Characterization of clinical isolates of Acinetobacter baumannii and comparative proteomic profiling among strong and weak biofilm formersMicrobiology Spectrum · 2026
7. The RNA m6A reader YTHDF2 depletion phenocopies high glucose induced-cellular stress response in diabetic kidney disease2026
8. Time of day metabolism and endocrine regulation of immune healthFrontiers in Molecular Medicine · 2026
9. In Situ Generation of Arylacetyl Radicals and Their Unexplored Acylation with AminesThe Journal of Organic Chemistry · 2026
10. Neuroinflammation in Alzheimer’s disease: pathogenic signaling, biomarkers, and emerging therapeutic interventionsFrontiers in Oncology · 2026
11. Therapeutic prospects of thiazolo[3,2- b ][1,2,4]triazole derivatives: a comprehensive review of biological activities and structure–activity relationship insightsFuture Medicinal Chemistry · 2026
12. Biased signaling of endothelial GPCRs as a therapeutic frontier in atherosclerosisJournal of Receptors and Signal Transduction · 2026
13. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023The Lancet · 2025
14. Development and psychometric validation of a barrier assessment tool for adherence to prescribed medication regimens in post-PCI patientsFuture Cardiology · 2026
15. Exploring the cardioprotective role of metformin against isoproterenol-induced myocardial infarction using computational, cellular, and animal models3 Biotech · 2026
16. Antiseizure drug-induced Stevens - Johnson syndrome and toxic epidermal necrolysis in children: a systematic reviewCutaneous and Ocular Toxicology · 2026
17. Computational drug design, synthesis, acetylcholinesterase inhibition and kinetic evaluation of novel benzothiazole-thiadiazole/oxadiazole derivativesFuture Medicinal Chemistry · 2026
18. Safety and efficacy of indigenous ultrathin-strut versus international thin-strut drug-eluting coronary stents in percutaneous coronary intervention: a systematic review of randomized controlled trialsExpert Review of Medical Devices · 2026
19. Naringenin microneedles as theranostics in the management of rheumatoid arthritisTherapeutic Delivery · 2026
20. Translational Pharmaceutical Perspectives on Quinones as Antioxidant and Antidiabetic Agents in Diabetes and Its ComplicationsPharmaceutics · 2026